Audit Agency

Office of the State Auditor

13 indexed reports

MA
2025

Review of Durable Medical Equipment Providers

Office of the State Auditor, Commonwealth of Massachusetts
Published 2025

MassHealth did not fully ensure that DME was not ordered by excluded providers or for deceased members, as evidenced by three identified findings and associated overpayments; ongoing post-payment and ...

NC
2025

Performance Audit Report July 2025 Medicaid Provider Enrollment Follow-Up Audit

North Carolina Office of the State Auditor
Published 2025

The Division of Health Benefits did not fully implement prior audit recommendations during 2023, leaving ongoing risks to patient safety and Medicaid integrity from providers with suspended licenses, ...

MA
2024

Office of Medicaid—Review of Capitation Payments With Multiple Identification Numbers

Office of the State Auditor (Massachusetts)
Published 2024

MassHealth did not ensure that capitation payments were not made on behalf of Medicaid beneficiaries who were assigned multiple IDs.

NJ
2024

Estate Recovery Audit Report

New Jersey Office of the State Auditor
Published 2024

The division had adequate controls to ensure compliance with federal and state regulations and general information system controls were in place and functioning. However, outdated policies and procedu...

CO
2024

Evaluation Of The Colorado Recovery Audit Contractor Program

Colorado Office of the State Auditor
Published 2024

HCPF’s Medicaid Recovery Audit Contractor program generally adheres to federal and state requirements but requires stronger contract oversight and program management to ensure efficient operation, red...

MA
2024

Medicaid Audit Unit—Annual Report

Office of the State Auditor (Massachusetts)
Published 2024

The audit identified an estimated $84,832,094 in capitation payments to MassHealth members residing outside Massachusetts. MassHealth has reported actions or planned actions on all four audit recommen...

CO
2023

Medicaid Correspondence Performance Audit

Colorado Office of the State Auditor
Published 2023

The audit concluded that the Department of Health Care Policy & Financing’s Medicaid correspondence exhibits significant clarity, accuracy, and completeness problems across CBMS and non-CBMS letters, ...

MA
2023

Office of Medicaid (MassHealth) — Review of Capitation Payments

Office of the State Auditor
Published 2023

MassHealth did not ensure that it does not make capitation payments to MCOs on behalf of ineligible members who reside outside Massachusetts; the State Auditor identified approximately $84.8 million i...

MA
2022

MassHealth Telehealth Review

Office of the State Auditor (Massachusetts)
Published 2022

MassHealth did not monitor telehealth practices to ensure compliance with its All Provider Bulletins for telehealth encounters, leading to at least $91,852,881 in potentially improper payments.

MA
2022

Office Of Medicaid (MassHealth)—Massachusetts Delivery System Reform Incentive Payment Program

Office of the State Auditor (Massachusetts)
Published 2022

MassHealth did not ensure that DSRIP funding was allocated to ACOs in accordance with the Massachusetts Delivery System Reform Incentive Payment Protocol (Attachment M).

MA
2021

MassHealth Payments for Hospice-Related Services for Dual-Eligible Members

Office of the State Auditor (Massachusetts)
Published 2021

MassHealth did not administer payments to non-hospice providers for hospice-related services in compliance with applicable state and federal regulations, including ensuring that Medicaid is payer of l...

NC
2021

Medicaid Provider Enrollment Performance Audit

North Carolina Office of the State Auditor
Published 2021

The Medicaid Provider Enrollment process in North Carolina did not adequately ensure that only qualified providers were enrolled to serve Medicaid beneficiaries or to receive payments. The Division fa...

MO
2018

Department of Social Services Prescription Drug Oversight

Missouri Office of the State Auditor
Published 2018

The audit found that while cost containment measures have contributed to reductions in prescription drug payments after 2015, significant control gaps remain, notably the absence of a comprehensive st...